期刊文献+

CpG-DNA特征结构与其免疫刺激特性的关系 被引量:2

The Relation between the Specific Structure and Immunostimulatory Function of CpG-DNA
暂未订购
导出
摘要 CpG-DNA是一些具有免疫激活功能的以未甲基化的CpG基序为核心的DNA序列,它包括含CpG基序的人工合成的寡聚脱氧核苷酸(oligodeoxynucleotides,ODN)和自然界中细菌、病毒、无脊椎动物等低等生物的基因组DNA。CpG基序(CpG motifs)是指一类以非甲基化的胞嘧啶和鸟嘌呤核苷酸为核心的寡聚脱氧核糖核苷酸,其碱基排列大多遵循以下规律:5’端为2个嘌呤,3’端为2个嘧啶。研究表明,这种序列可激活多种免疫效应细胞,其特征结构如CpG核心、侧翼序列、骨架长度等都对其免疫刺激特性有重要影响。本文就其特征结构与免疫刺激特性的关系作一介绍。 CpG-DNA is DNA sequence that contains unmethylated CpG motifs and has immunostimulatory effect. It includes synthetic oligodeoxynucleotides containing unmethylated CpG motifs and genome DNA of low animal in nature such as bacterium, virus , invertebrate animal and so on. CpG motifs is unmethylated oligodeoxynucleotides that has the core composed by unmethylated deoxycytidine monophosphtes and unmethylated deoxyguanosine monophosphates. The range of Motif has a law that 5' - terminal has two purines and 3' - terminal has two pyridines. Some studies Showed that these motifs are able to stimulate immune cells, and that the specific structures (such as CpG core, terminal sequences, the length of skeleton framework and so on) have significant effect to immunostimulatory function. This study showed the relation between the specific structure and the immunostimulatory function.
出处 《吉林农业科技学院学报》 2007年第1期17-19,共3页 Journal of Jilin Agricultural Science and Technology University
关键词 CPG基序 特征结构 免疫刺激特性 CpG motif specific structure immunostimulatory function
  • 相关文献

参考文献3

二级参考文献11

  • 1[1]Krieg A M,Yi A K,Matson S,et al.Nature,1995;374:546-549.
  • 2[2]Yi A K,Klinman D M,Martin T L,et al.J Immunol,1996; 157:5394-5402.
  • 3[3]Weiner G J,Liu H M,Wooldridge J E,et al .Proc Natl Acad Sci USA,1997; 94:10833-10837.
  • 4[4]Chu R S,Targoni O S,Krieg A M,et al.J Exp Med,1997; 186(10):1623-1631.
  • 5[5]Stacey K J,Sweet M J,Hume D A .J Immunol,1996; 157:2116-2122.
  • 6[6]Lipford G B,Sparwasser T,Bauer M,et al.Eur J Immunol,1997; 27:3420-3426.
  • 7[7]Sparwasser T,Koch E S,Vabulas R M,et al .Eur J Immunol,1998; 28:2045-2054.
  • 8[8]Ballas Z K,Rasmussen W L,Krieg A M .J Immunol,1996; 157:1840-1845.
  • 9[9]Sun S,Beard C,Jaenisch R,et al.J Immunol,1997;159:3119-3125.
  • 10[10]Klinman D M,Yi A K,Beaucage S L,et al.Proc Natl Acad Sci USA,1996; 93:2879-2883.

共引文献10

同被引文献18

  • 1殷翔,周红.CpG寡核苷酸的免疫刺激作用及其在疫苗中的应用[J].国外医学(药学分册),2004,31(4):222-226. 被引量:5
  • 2李杰,杨汉春,郭鑫,陈艳红,查振林.CpG ODN对鸡新城疫LaSota活疫苗的免疫增强效应[J].畜牧兽医学报,2006,37(1):44-49. 被引量:13
  • 3张玲华,田兴山,周风珍.CpG ODN对仔猪淋巴细胞增殖和细胞因子诱生的影响:在体和离体试验[J].中国兽医学报,2007,27(1):46-50. 被引量:1
  • 4HEMMI H,TAKEUCHI O,KAWAi T. A Toll-like receptor recognizes bacterial DNA[J].Nature,2000,(6813):740-745.doi:10.1038/35047123.
  • 5LOPEZ A M,HECKER R,MUTWIRI G. Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine[J].Vet Immunol Immunopatho1,2006,(1-2):103-110.
  • 6MOLDOVEANU Z,LOVE-HOMAN L,HUANG W Q. CpG DNA,a novel immune enhancer for systemic and mucosal immunzation with influenza virus[J].Vaccine,1998,(11-12):1216-1224.
  • 7SHI T,LIU W Z,GAO F. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori,and T helper 1 type response and interferongamma correlate with the protection[J].Helicobacter,2005,(01):71-79.doi:10.1111/j.1523-5378.2005.00293.x.
  • 8CARPENTIER A F,AUF G,CHEN L. Implication of macrophages in tumor rejection induced by CpG-oligodeoxynucleotides without antigen[J].Clinical Cancer Research,2001,(11):3540-3543.
  • 9BOURQUIN C,SCHREIBER S,BECK S. Immunotherapy with den- dritic cells and CpG oligonucleotides can be combined with chemotherapy without loss of efficacy in a mouse model of colon cancers[J].International Journal of Cancer,2006,(11):2790-2795.
  • 10JAIN V V,BUSINGA T R,KITAGAKI K. Mucosal immunotherapy with CpG oligodeoxynucleotides reverses a murine model of chronic asthma induced by repeated antigen exposure[J].American Journal of Physiology-Lung Cellular and Molecular Physiology,2003,(05):1137-1146.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部